Krystal Biotech, Inc.
KRYSNASDAQNASDAQ Global Market·USD·Closed
$279.24
−$0.10 (0.04%)
$279.24
−$0.10 (0.04%)
Not investment advice.Learn more
KRYS leans slightly negative — a few concerns outweigh the positives.
The stock is priced moderately relative to its earnings
This company doesn't pay a dividend
A mid-sized company. Balances growth potential with stability
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Near 52-week high
Volume
Market Cap
Mid-cap company
P/E Ratio
Moderately valued
Div Yield
No dividend